Lazarus

Lazarus

Enterprise AI for regulated document understanding

Overview

Lazarus provides AI models that extract and analyze data from unstructured documents like medical records and legal agreements for organizations in regulated industries. Its RikAI model identifies text and handwriting in over 100 languages, while the ATLS system coordinates different tools to automate complex workflows through a secure, private cloud or on-premise API. Unlike many competitors, the platform handles multiple data formats like audio and video and provides transparent logs that explain the reasoning behind every output. The company's goal is to help businesses automate data intake and turn their physical or digital documents into searchable, actionable knowledge.

Significant Headcount Growth

About Lazarus

Simplify's Rating
Why Lazarus is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Seed

Total Funding

$5.3M

Headquarters

Cambridge, Massachusetts

Founded

2017

Get referred to Lazarus

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2025 Nissay-backed financing deepens distribution into Japan's insurance market.
  • Lazarus claims 20% of top global insurers and 50% of northeastern prior authorizations.
  • March 2026 early adopters cut prior authorization reviews to hours and found $30 million exposure.

What critics are saying

  • OpenAI, Google, and AWS bundle document AI, compressing Lazarus' pricing power by 2027.
  • Insurance concentration exposes revenue to one vertical and Nippon Life's procurement cycles.
  • One failed regulated deployment can trigger audits, contract losses, and destroy enterprise trust.

What makes Lazarus unique

  • RikAI and ATLS target regulated workflows, not generic chatbots, with auditable reasoning.
  • March 2026 AIE made Lazarus model-independent, bridging pilots to production for enterprises.
  • Nippon Life partnered since 2023, and AllegisNL funded expansion into Japan.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$5.3M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$5.3M
Lazarus

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Flexible Work Hours

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

11%

2 year growth

23%
FinSMEs
Mar 27th, 2025
Lazarus AI Secures Funding from AllegisNL

Lazarus AI, based in Cambridge, MA, secured financing from AllegisNL Capital to expand into the Japanese insurance market. The funding amount was not disclosed. Lazarus AI, led by CEO Ariel Elizarov, specializes in AI solutions for regulated industries. AllegisNL Capital is backed by Nippon Life Group, with whom Lazarus AI has a service partnership since 2023.

Business Wire
Mar 26th, 2025
Japan’s Largest Life Insurer, Nissay, funds Lazarus AI via AllegisNL Capital

Lazarus AI has successfully secured participation from AllegisNL Capital into the convertible note financing. AllegisNL Capital is a venture capital fund sup...

Coverager
Nov 1st, 2024
QBE Ventures backs Lazarus AI

Lazarus AI currently has customers in the healthcare, banking and insurance industries.

Recently Posted Jobs

Sign up to get curated job recommendations

Lazarus is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →